Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 164

Similar articles for PubMed (Select 9506641)

1.

The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women.

Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, Darragh TM, Brescia R, Kanowitz S, Miller SB, Stone J, Hanson E, Palefsky J.

J Pediatr. 1998 Feb;132(2):277-84.

PMID:
9506641
2.

Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study.

Branca M, Costa S, Mariani L, Sesti F, Agarossi A, di Carlo A, Galati M, Benedetto A, Ciotti M, Giorgi C, Criscuolo A, Valieri M, Favalli C, Paba P, Santini D, Piccione E, Alderisio M, De Nuzzo M, di Bonito L, Syrjänen K.

Eur J Gynaecol Oncol. 2004;25(6):689-98.

PMID:
15597844
3.

Different risk factor patterns for high-grade and low-grade intraepithelial lesions on the cervix among HPV-positive and HPV-negative young women.

Krüger-Kjaer S, van den Brule AJ, Svare EI, Engholm G, Sherman ME, Poll PA, Walboomers JM, Bock JE, Meijer CJ.

Int J Cancer. 1998 May 29;76(5):613-9.

PMID:
9610715
4.

Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.

Schlecht NF, Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JC, Ferenczy A, Rohan TE, Villa LL, Franco EL.

J Natl Cancer Inst. 2003 Sep 3;95(17):1336-43.

5.

Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women.

Castle PE, Wacholder S, Sherman ME, Lorincz AT, Glass AG, Scott DR, Rush BB, Demuth F, Schiffman M.

Cancer. 2002 Nov 15;95(10):2145-51.

6.

Human papillomavirus infection and cervical intraepithelial neoplasia in a cohort of low-risk women.

Nyári T, Kalmár L, Nyári C, Parker L, Kovács L, Thurzó L.

Eur J Obstet Gynecol Reprod Biol. 2006 Jun 1;126(2):246-9. Epub 2005 Nov 23.

PMID:
16309820
7.

Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.

Dalstein V, Riethmuller D, Prétet JL, Le Bail Carval K, Sautière JL, Carbillet JP, Kantelip B, Schaal JP, Mougin C.

Int J Cancer. 2003 Sep 1;106(3):396-403.

PMID:
12845680
8.

Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN).

Acladious NN, Sutton C, Mandal D, Hopkins R, Zaklama M, Kitchener H.

Int J Cancer. 2002 Mar 20;98(3):435-9.

PMID:
11920596
9.

Spontaneous evolution of human papillomavirus infection in the uterine cervix.

Paraskevaidis E, Kalantaridou SN, Georgiou I, Koliopoulos G, Pappa L, Malamou-Mitsi V, Agnantis NJ, Kitchener HC, Lolis DE.

Anticancer Res. 1999 Jul-Aug;19(4C):3473-8.

PMID:
10629638
10.

Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization.

Costa S, De Simone P, Venturoli S, Cricca M, Zerbini ML, Musiani M, Terzano P, Santini D, Cristiani P, Syrjänen S, Syrjänen K.

Gynecol Oncol. 2003 Aug;90(2):358-65.

PMID:
12893200
11.
12.
13.

Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.

Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A, Piccione E, Branca M, Syrjänen K, Favalli C.

Eur J Gynaecol Oncol. 2004;25(5):577-84.

PMID:
15493169
14.

Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus.

Moscicki AB, Ellenberg JH, Vermund SH, Holland CA, Darragh T, Crowley-Nowick PA, Levin L, Wilson CM.

Arch Pediatr Adolesc Med. 2000 Feb;154(2):127-34.

PMID:
10665598
16.

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M.

J Natl Cancer Inst. 2003 Jan 1;95(1):46-52.

17.

Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.

Hawes SE, Critchlow CW, Sow PS, Touré P, N'Doye I, Diop A, Kuypers JM, Kasse AA, Kiviat NB.

J Natl Cancer Inst. 2006 Jan 18;98(2):100-9.

18.

Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States.

Hildesheim A, Schiffman M, Scott DR, Marti D, Kissner T, Sherman ME, Glass AG, Manos MM, Lorincz AT, Kurman RJ, Buckland J, Rush BB, Carrington M.

Cancer Epidemiol Biomarkers Prev. 1998 Nov;7(11):1035-41.

20.

Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear.

Arora R, Kumar A, Prusty BK, Kailash U, Batra S, Das BC.

Eur J Obstet Gynecol Reprod Biol. 2005 Jul 1;121(1):104-9.

PMID:
15950365
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk